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Nicotine cigarette smoke is a large public health burden worldwide, contributing to various
types of disease. Anti-tobacco media campaigns and control programs have signiﬁcantly
reduced smoking in the United States, yet trends for menthol cigarette smoking have not
been as promising. Menthol cigarette smoking is particularly prevalent among young adults
and African Americans, with implications for long-term impacts on health care. Continuing
high rates of menthol cigarette addiction call into question the role of menthol in nicotine
addiction. To date, a biological basis for the high rate of addiction and relapse among
menthol cigarette smokers has not been deﬁned. Studies have demonstrated a role for
menthol in the metabolism of nicotine in the body. More recent ﬁndings now reveal an
interaction between menthol and the nicotinic acetylcholine (nACh) receptor in cells. This
receptor is central to the actions of nicotine in the brain, and plays an important role in
nicotine addiction. The newly discovered effect of menthol on nACh receptors may begin
to explain the unique addictive properties of menthol cigarettes.
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BEYOND FLAVOR: MENTHOL’S SUCCESS AS AN ADDITIVE TO
CIGARETTES
Menthol is amonocyclic terpene alcohol used widely as a ﬂavoring
in various pharmaceutical and commercial products (Eccles, 1994;
Heck,2010). It is also a commonadditive to tobacco cigarettes. The
isomer l-menthol, which has been used as an additive in cigarettes
since 1926, is extracted from the peppermint plant Mentha arven-
sis. The concentration of menthol in cigarettes varies by brand
but is present in 90% of all tobacco products (Farco and Grund-
mann, 2013). It is used inmenthol cigarettes tomask the harshness
of smoke inhalation, increase the ease of smoking, and provide
an oral sensation that appeals to many smokers. Today, menthol
cigarettes account for 25% of the cigarette market in the United
States (Heck, 2010; Hoffman and Simmons, 2011).
Targeted marketing strategies since the 1930’s have been effec-
tive in promoting smoking in young adults, women, and African
Americans (Rosenbloom et al., 2012; Dauphinee et al., 2013;
Figure 1). In theUnited States, the rate ofmenthol cigarette use has
not receded even as the overall rate of smoking has declined in the
general population. Young adults and teenagers in particular are
more likely to try menthol cigarettes. Incidentally, young people
who take upmenthol cigarettes are 80%more likely to become life-
long smokers than those who consume regular cigarettes (Friend,
2002; D’Silva et al., 2012). These ﬁndings present an important
question for public health regulators and scientists: are menthol
cigarettes more addictive than other cigarettes? Negative ﬁndings
with respect to the impact of mentholated cigarettes on cancer,
smoking initiation and other health issues exist (Rose and Behm,
2004;Werley et al., 2007; Hoffman andMiceli, 20111). In this arti-
cle, I explore how recent ﬁndings on interactions betweenmenthol
1The study was supported by tobacco industry funding.
and nicotinic acetylcholine (nACh) receptors can shed new light
on the addictive potential of menthol cigarettes.
DOES MENTHOL CONTRIBUTE TO ADDICTION?
Traditionally, research into the addictive properties of tobacco
cigarettes has focused on the actions of nicotine in the brain.
The role of menthol has been attracting increasing attention, and
emerging research suggests that menthol’s role in tobacco addic-
tion deserves even closer scrutiny. One of the more signiﬁcant
scientiﬁc suggestions is that menthol can alter the metabolism of
nicotine in the body. This effect of menthol is shown to pro-
vide smokers an enhanced exposure to systemic nicotine and
its metabolites (Benowitz, 2008). In accordance with this idea,
menthol cigarette smokers on the whole are known to exhibit
different smoking habits from other smokers. For example, they
tend to smoke fewer cigarettes per day, and ﬁnd it more difﬁcult
to quit (Oliver et al., 2013). Relapse rates are also considerably
higher in menthol cigarette smokers suggesting that menthol may
contribute more than just ﬂavor.
Menthol is known to directly activate the cold sensitive tran-
sient receptor potential melastatin (TRPM) ion channel in cells,
which contributes to the cool nasal and oral sensation provided by
menthol. Additionally, menthol has been shown to depress respi-
ration and enhance nicotine’s presence in the lungs (Janssens and
Voets, 2011). How the mechanisms of menthol’s actions impact
nicotine addiction, on the other hand, is not clear.
WAYS IN WHICH MENTHOL CAN CONTRIBUTE TO
ADDICTION
MENTHOL ALTERS NICOTINE METABOLISM
A number of scientiﬁc studies show that menthol inhibits the
metabolism of nicotine, thereby enhancing nicotine delivery via
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FIGURE 1 |Who smokes menthol cigarettes? (A) Advertisements used in the marketing and branding of menthol cigarettes. (B) Data gathered from the
Tobacco Products Scientiﬁc Advisory Committee’s original report (Wilson, 2011) on the percent menthol smokers in various ethnic, racial, gender, and age
groups. Values are based on data obtained in 2008.
menthol cigarettes (Benowitz, 2008). Smoking menthol cigarettes
appears to also increase systemic exposure to tobacco smoke toxins
and other toxins such as carbon monoxide, possibly by affecting
the metabolism of nicotine (Hoffman, 2011). Differences in nico-
tine metabolism prevail in the general population. These can be
accounted for by genetic as well as environmental factors. African-
Americans, in particular, appear tometabolize nicotine to its main
metabolite cotinine more slowly, and to metabolize cotinine itself
more slowly (Benowitz et al., 2011).Whether genetic and environ-
mental factors also predispose individuals to an altered response to
menthol is interesting to consider. A number of reviews have been
published on this topic (Benowitz, 2009; Ahijevych and Garrett,
2010; Hoffman and Simmons, 2011), and therefore it will not be
discussed in this article.
MENTHOL INTERACTS WITH THE NICOTINIC RECEPTOR
While nicotine is considered to mediate most of the pharmaco-
logical and addictive properties of tobacco via the actions of the
nACh receptor in the brain (Albuquerque et al., 2009; Berrettini
and Doyle, 2012; Picciotto and Kenny, 2013), a new line of evi-
dence suggests that menthol also regulates nACh receptor activity
(Ahijevych and Garrett, 2010; Fagan et al., 2010; Hoffman and
Simmons, 2011). During the past year, work from various labs has
shown that menthol can directly modulate the pharmacological
actions of nicotine on the nACh receptor. In doing so, menthol
is found to alter the effect of nicotine in neural cells (Hans et al.,
2012; Ashoor et al., 2013). An additional new study reveals that
the density of nACh receptors in the brain of menthol cigarette
smokers is considerably higher than that of non-menthol smokers
(Brody et al., 2013). Taken together, these emergent ﬁndings sug-
gest a new framework for understanding the role of menthol in
nicotine addiction.
Menthol directly regulates the actions of the nicotinic receptor in
the cell
Prolonged cigarette smoking is associated with an increase in
nACh receptor density throughout the brain (Picciotto andKenny,
2013). This process of receptor “up-regulation” is likely to play
an important role in the physiological underpinnings of nico-
tine addiction. A similar mechanism of receptor up-regulation
occurs in rodents in response to chronic nicotine administra-
tion (Le Foll and Goldberg, 2009). This process accompanies a
propensity to self-administer nicotine (Moretti et al., 2010) thus
suggesting that these alterations in nACh receptor levels contribute
to nicotine addiction. A new study by Brody et al. (2013) shows
that smokers of menthol cigarettes also exhibit an up-regulation
in nACh receptors throughout the brain. The up-regulation in
nACh receptor levels is signiﬁcantly higher, however, in smok-
ers of menthol cigarettes than other types of cigarettes. Using
positron emission tomography (PET) to visualize the density
of α4β2 nACh receptors, the authors ﬁnd that menthol smok-
ing is associated with a 9–28% rise in the levels of these nACh
receptors in regions such as the prefrontal cortex and corpus
callosum.
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Two other studies published this year by Hans et al. (2012)
and Ashoor et al. (2013) highlight a shared mechanism of action
for menthol on nACh receptors. These studies show that menthol
directly attenuates the activation of the nACh receptor by nicotine.
Single channel recordings, combined with whole cell patch clamp
analysis, reveal that menthol decreases the ability of nicotine to
activate the nACh receptor. In the case of the α4β2 nACh receptor,
interaction with menthol appears to be most favorable when the
receptor is in the closed state (Hans et al., 2012). Similar ﬁndings
are reported for the α7 nACh receptor, which demonstrate that
menthol inhibits the responsiveness of the receptor to nicotine in
cells (Ashoor et al., 2013). The amount of menthol used in the
above experiments is consistent with one report on the levels of
menthol detected in the brain tissue of mice (Pan et al., 2012).
Together, these studies corroborate menthol’s ability to regulate
nACh receptors in the brain2.
Structural modeling based on sequence homology and docking
simulations was also provided inAshoor et al. (2013). The compu-
tational perspective suggests two energetically favorable residues
within the nACh receptor protein for menthol binding. The prox-
imity of the two residues within the nACh receptor implies a
possible menthol-binding site within the nACh receptor chan-
nel. Interestingly, this putative binding site appears well outside
of the nicotine-binding pocket, and suggests that menthol can
function as an allosteric modulator of the nACh receptor (Ashoor
et al., 2013; Figure 2). The structural modeling data supports
experimental evidence on the actions of menthol on the nACh
receptor. In particular, studies show that menthol attenuates the
nACh receptor channel response to nicotine in a dose-dependent,
2Liquid chromatographymeasures of freementhol in the brain of mice after a single
intraperitoneal injection of menthol (100 mg/Kg), indicate 54.6 μg/g and 5 μg/g at
5 and 60 min after injection, respectively (Pan et al., 2012). Calculations based on
an average adult mouse weight suggest that the levels of menthol in the brain are
between 30 and 350 μM
non-competitive manner, and does not interfere with the kinetics
of the nACh receptor channel (Hans et al., 2012; Ashoor et al.,
2013). Taken together, the ﬁndings prove that menthol modi-
ﬁes the responsiveness of the nACh receptor to nicotine, thereby
potentially affecting nicotine’s action in the brain.
Menthol alters the addictive properties of nicotine
Nicotinic receptors play a key role in addiction by regulating the
release of several important neurotransmitters in the brain (Pic-
ciotto and Kenny, 2013). Nicotine directly enhances dopamine
levels in the mesolimbic system by interacting with nACh recep-
tors ondopaminergic neurons in the ventral tegmental area (VTA).
Nicotine can also regulate the release of glutamate and GABA by
binding to nACh receptors within the VTA (Grabus et al., 2005;
Maskos, 2008). The expression of nACh receptors in regions such
as the nucleus accumbens, hippocampus, amygdala, and pre-
frontal cortex enables nicotine to inﬂuence brain functions that
contribute to addiction, including memory and decision making.
These receptors are also present on neurons that release other
neurotransmitters, including opioids, norepinephrine, serotonin,
and cannabinoids (Maskos, 2008). However, the role of these
neurotransmitters in nicotine dependence is not clear.
Strong preclinical evidence suggests that β2, α4, α5, α6, and
α7 containing nAChRs mediate the reinforcing effects of nicotine
(Changeux, 2010). A genetic variation in the human α7 nACh
receptor gene CHRNA7 has also been linked to tobacco depen-
dence (Albuquerque et al., 2009; Berrettini and Doyle, 2012). Mice
with a deletion of the α7, α4, or β2 gene are viable, but exhibit
altered responses to nicotine (Stoker andMarkou,2013). In behav-
ioral studies, activation of α7 as well as α4β2 nACh receptors
strongly correlates with an animal’s propensity to self-administer
nicotine (Le Foll and Goldberg, 2009). Thus, if menthol modu-
lates the function of these nACh receptors, it is plausible that it also
modiﬁes the addictive properties of nicotine in the brain. In one
FIGURE 2 | A role for menthol in modulating the activation of the
α7 nACh receptor. (A) Nicotine is a known to bind and activate the α7
nACh receptor channel at the plasma membrane. Upon binding nicotine,
the nACh receptor channel opens conducting calcium (and sodium) into
the cell. (B) New ﬁndings by Ashoor et al. (2013) reveal that nicotine does
not activate the α7 nACh receptor channel to the same extent when
co-applied with menthol. Similar ﬁndings have also been reported for
α4β2 nACh receptors (Hans et al., 2012). Threonine 252 within the
α7 nACh receptor has been suggested to contribute to menthol
binding.
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scenario, menthol can directly modulate the actions of nicotine
on the α7nACh receptor as supported by ﬁndings in Ashoor et al.
(2013). Electrophysiological data suggests that menthol attenuates
the channel’s response to nicotine (Figure 2). At present however
it is not certain that menthol does not alter the afﬁnity of nico-
tine for the nACh receptor. Studies on the affect of menthol in α
bungarotoxin binding to the α7 nACh receptor, suggest that men-
thol does not impact the binding of the receptor to this ligand
(Ashoor et al., 2013). The ﬁndings, however, are based on patch-
clamp experiments in oocytes and do not explore the effects of
menthol on nACh receptor interaction with nicotine. The results
therefore should be examined further in order to better understand
how menthol modulates the activation of the nACh receptor by
nicotine.
For the α7 nACh receptor channel, which opens with a strong
inward depolarizing calcium (and sodium) current in response
to nicotine (Albuquerque et al., 2009), simultaneous exposure to
menthol is predicted to attenuate the channel response (Figure 2).
Mechanistically, menthol can do this by potentiating the desensi-
tization of the channel, or by inhibiting its full activation by the
agonist. In either case, the short-term effect of weakening the α7
nACh receptor signal in neurons appears to correlate with a state
of craving and an increase in motivation to smoke (as discussed
below; Brunzell and McIntosh, 2012). In the long-term, menthol
may promote up-regulation in nACh receptors in the brain. This
is supported by the ﬁnding in Brody et al. (2013), which indicate
higher levels of α4β2 receptors in the brain of menthol cigarette
smokers relative to non-menthol smokers. The effects of men-
thol on nACh receptor expression may play a role in addiction
to nicotine as well as in the difﬁculty to quit smoking menthol
cigarettes.
How menthol can engage the brain’s reward pathway is an
important scientiﬁc question to consider. The role of menthol
cigarettes in increasing the reinforcing effects of nicotine has been
recently explored in rodents (Abobo et al., 2012). Menthol has
been found to alter the dopamine system in rodents by inter-
acting with the dopamine uptake inhibitor bupropion (Umezu
and Morita, 2003). Future studies in rodents, as well as humans,
should shed light on the relevance andproperties of the interaction
between nACh receptors and menthol. Because a decrease in α7
nACh receptor function appears sufﬁcient to alter the motiva-
tion to smoke, increases nicotine self-administration, and alter the
function of the dopamine system in rodents (Brunzell and McIn-
tosh, 2012), it is plausible thatmenthol can contribute to addiction
by attenuating the nACh receptor.
CONCLUSION
Recent ﬁndings on the ability of menthol tomodulate nACh recep-
tors suggest an important role for this compound in smoking
addiction. While compelling, these studies are not yet conclusive.
Rather, these ﬁndings point to the need for more studies to deter-
mine if and how menthol affects the activity of nACh receptors
in the brain. Experiments using subunit speciﬁc nACh receptor
knockout mice are a clear next step in the pharmacological and
behavioral analysis ofmenthol function. Ex vivo studies in cultured
cells and brain slices are also important to conﬁrm and charac-
terize interactions between menthol and the nACh receptor. For
example, studies that examine menthol’s effects on nicotine self-
administration in rodents will enable the assessment of dopamine
(and glutamate release) in the brain following the administration
of nicotine or nicotine with menthol. Subunit speciﬁc knockout
mice for theα4,βb2,andα7subunitsaswell asothernAChreceptors
(Changeux, 2010), will permit testing of menthol’s effect on vari-
ous types of receptors. Lastly, genetic testing for polymorphisms in
nACh receptor genes in smokers may provide clues on why some
people are more prone to menthol cigarette addiction. Findings
on genetic variability in nicotinemetabolism inAfricanAmericans
clearly suggest a role for genes in (nicotine) addiction (Benowitz
et al., 2011). Recent work has also linked variants in genes encod-
ing the α3, α5, and β4 nACh receptor subunits to smoking risk in
the general population (Wang et al., 2012). If menthol were indeed
found to impact the function of nACh receptors, a clear discus-
sion would then be warranted about the addictive properties and
public health implications of menthol nicotine cigarettes.
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